SARS-CoV-2 binding to ACE2 leads to down-regulation of ACE2 expression, disrupting the balance of the RAS system, exacerbating lung injury and contribute to the pathogenesis of pulmonary hypertension and insufficiency. The gene discussed is ACE2; the disease is pulmonary hypertension.